Having trouble viewing this email? View it in your browser.
Musella Foundation Logo and Name of Email Blast
Monday, September 29, 2025
Issue 6027
Donations

Advocacy
Alert

The time has come to rally for the Promising Pathway Act!

Click for details and to easily send letters.

Latest News

  • Guiding principles for adult CNS tumor treatment programs        

    A new paper published in Neuro-Oncology Advances introduces the first-ever Guiding Principles for Adult CNS Tumor Treatment Programs in the United States. This was a joint effort among several brain tumor patient advocacy organizations, including the Musella Foundation. These principles fill a critical gap by defining what specialized, comprehensive care for brain and CNS tumor patients should include, such as expert multidisciplinary teams, molecular testing, access to clinical trials, and supportive services. The full guidelines are now publicly available to help patients and caregivers make more informed treatment decisions.


  • The 25th Annual UCLA Brain Tumor Conference will now be online!        
    The annual UCLA brain tumor conference will now be an online virtual event in order to provide patients and caregivers the opportunity to learn more about brain tumors, standard treatments, experimental therapies, symptom management, nutrition, community resources, and other important topics. Sessions will begin on Wednesday, October 1, and will continue throughout the month of October. The conference is free and open to all; to access conference content, click here.


Sponsored By
Chimerix
Please Click On The Above Banner For More Details

To view past stories go to : https://virtualtrials.org/newsblast.cfm
To submit a story/press release go to: click here To unsubscribe, click here.
The article commentaries are the opinions of Al Musella, DPM and do not represent the official position of the Musella Foundation. Copyright 1992-2025 Musella Foundation - All rights reserved. No part of the Brain Tumor News Blast can be reproduced without the express written permission of the Musella Foundation.